Baccioglu, AyseBavbek, Sevim2021-01-142021-01-142020Baççıoğlu, A., & Bavbek, S. (2020). Asthma as A Comorbid Disease in COVID-19. Asthma Allergy Immunology. 18(1), 1-7.1308-9234https://doi.org/10.21911/aai.565https://hdl.handle.net/20.500.12587/12830Bavbek, Sevim/0000-0002-7884-0830Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that causes coronavirus disease 2019 (COVID-19). In terms of asthma and COVID-19, there is also a risk of experiencing an asthma exacerbation triggered by coronavirus infection beyond the direct risk of the infection itself. As a comorbid disease, the prevalence of COVID-19 infection in asthma patients is not clear. In addition, the influence of asthma on the severity of COVID-19 has not been reported. The aim of this review was to summarize the reported worldwide data about the prevalence and the clinical characteristics of patients with asthma during COVID-19 infection.eninfo:eu-repo/semantics/openAccessAsthmasevere asthmaasthma attackviral infectioncoronavirus disease 2019COVID-19SARS-CoV-2Review Article181710.21911/aai.5652-s2.0-85153862887Q4WOS:000592369300002N/A